Dicerna Pharmaceuticals Inc
Officers & Directors
1. Douglas M. Fambrough Jr. - President and CEO
Douglas M. Fambrough Jr. has been the President and CEO of Dicerna Pharmaceuticals Inc. since 200 He has over 25 years of experience in the biotechnology industry and has worked with several leading companies. He completed his undergraduate studies in Neuroscience at Amherst College and got his Ph.D. in Biology from the Massachusetts Institute of Technology.
2. Bob D. Brown - Executive VP and CFO
Bob D. Brown has been the Executive VP and CFO of Dicerna Pharmaceuticals Inc. since . He brings over 25 years of experience in finance and operations within the biotech industry. He obtained his Bachelor's degree in Accounting from Indiana University and is a certified public accountant.
3. Jane Rhodes - Vice President, General Counsel, and Corporate Secretary
Jane Rhodes has served as the Vice President, General Counsel, and Corporate Secretary of Dicerna Pharmaceuticals Inc. since 2016. She has over 25 years of experience as a legal counsel and has worked in several industries, including biotech and pharmaceuticals. She received her Juris Doctorate from Syracuse University.
4. Ralf Rosskamp MD - Chief Medical Officer
Ralf Rosskamp has been the Chief Medical Officer of Dicerna Pharmaceuticals Inc. since 2019. He has over 20 years of experience in the biotech and pharmaceutical industries and has specialized in drug development for multiple therapeutic areas, including RNAi. He holds a Medical Degree from the University of Tebingen in Germany.
5. Douglas M. Fambrough III - Director
Douglas M. Fambrough III has been a Director of Dicerna Pharmaceuticals Inc. since 2010. He has a background in biomedical engineering and has co-founded several biotech companies in the past. He obtained his Bachelor's degree in Biomedical Engineering from Duke University and his Ph.D. in Biomedical Engineering from the Massachusetts Institute of Technology.
6. Paul S. Schimmel, PhD - Director
Paul S. Schimmel has been a Director of Dicerna Pharmaceuticals Inc. since 2015. He is a renowned researcher in the field of RNA biology and has over 40 years of experience in biotech research. He is a professor at the Skaggs Institute for Chemical Biology at The Scripps Research Institute and received his Ph.D. in Biophysical Chemistry from the Massachusetts Institute of Technology.
Amy Schulman - Director
Amy Schulman has been a Director of Dicerna Pharmaceuticals Inc. since 2016. She has over 20 years of experience in the healthcare industry and has worked with several prominent companies. She is currently a Managing Partner of Polaris Partners and has a Juris Doctorate from Yale Law School.
Dicerna Pharmaceuticals Inc currently has 190 employees.
|
